104 related articles for article (PubMed ID: 8267668)
1. Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activity.
Safak C; Erdemli I; Sunal R
Arzneimittelforschung; 1993 Oct; 43(10):1052-5. PubMed ID: 8267668
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
3. 3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities.
Safak C; Ozkanli F; Erol K; Aktan Y
Arzneimittelforschung; 1995 Nov; 45(11):1154-6. PubMed ID: 8929229
[TBL] [Abstract][Full Text] [Related]
4. 2-methyl-3-acetyl-4-aryl-5-oxo-1,4-dihydro-5H indeno(1,2-b) pyridine derivatives studies and their calcium antagonistic activities.
Safak C; Simsek R; Altas Y; Boydag S; Erol K
Boll Chim Farm; 1997 Dec; 136(11):665-9. PubMed ID: 9534263
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, chemical and pharmacological properties of some 4-aryl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-diones.
Saraç S; Yarim M; Ertan M; Boydağ S; Erol K
Pharmazie; 1998 Feb; 53(2):91-4. PubMed ID: 9540105
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium modulatory activity of 3-alkyloxy-carbonyl-4-(disubstituted)aryl-5-oxo-1,4,5,6,7,8-hexa-hydroquinoline derivatives.
Simşek R; Oztürk GS; Vural IM; Gündüz MG; Sarioglu Y; Safak C
Arch Pharm (Weinheim); 2008 Jan; 341(1):55-60. PubMed ID: 17994603
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of hexahydroquinoline derivatives possessing calcium antagonistic activity.
Simşek R; Safak C; Erol K; Sirmagül B
Pharmazie; 2001 Aug; 56(8):665-6. PubMed ID: 11534349
[No Abstract] [Full Text] [Related]
8. Studies on 3-diethylaminocarbonyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium channel antagonistic activities in vitro.
Kismetli E; Safak C; Erol K; Sirmagül B; Linden A
Arzneimittelforschung; 2004; 54(7):371-5. PubMed ID: 15344840
[TBL] [Abstract][Full Text] [Related]
9. 4-difluoro-substituted phenl-5-oxohexahydroquinoline derivatives and their effects on calcium channels.
Simşek R; Gündüz MG; Sirmagül B; Safak C; Erol K; Linden A
Arzneimittelforschung; 2006; 56(7):529-34. PubMed ID: 16927535
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives.
Simşek R; Safak C; Erol K; Ataman S; Ulgen M; Linden A
Arzneimittelforschung; 2003; 53(3):159-66. PubMed ID: 12705170
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the Ca2+-antagonistic activity of some Bulgarian vasodilating agents and of known Ca2+-antagonists on K+-depolarized smooth muscle from guinea-pig taenia coli.
Mutafova-Yambolieva V; Staneva-Stoytcheva D; Nikolov R
Acta Physiol Pharmacol Bulg; 1989; 15(2):40-6. PubMed ID: 2801147
[TBL] [Abstract][Full Text] [Related]
13. Studies on calcium modulatory activities of 2,6,6-trimethyl-3-acetyl-4-aryl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives.
Altaş Y; Safak C; Batu OS; Erol K
Arzneimittelforschung; 1999 Oct; 49(10):824-9. PubMed ID: 10554659
[TBL] [Abstract][Full Text] [Related]
14. Ca-antagonistic activity of some 1,4-piperazine derivatives.
Seginko J; Dobrocký P; Cagánová B
Pharmazie; 1995 May; 50(5):368-9. PubMed ID: 7604073
[No Abstract] [Full Text] [Related]
15. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural elucidation and pharmacological properties of some 5-acetyl-3,4-dihydro-6-methyl-4-(substituted phenyl)-2(1H) -pyrimidinones.
Yarim M; Sarac S; Ertan M; Batu OS; Erol K
Farmaco; 1999 Jun; 54(6):359-63. PubMed ID: 10576776
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and calcium antagonistic activity of 2,6,6-trimethyl-3-carbomethoxy(ethoxy)-4-aryl-1,4,5,6,7,8-hexahydroquinoline derivatives.
Simşek R; Ismailoğlu UB; Safak C; Sahin-Erdemli I
Farmaco; 2000; 55(11-12):665-8. PubMed ID: 11204940
[TBL] [Abstract][Full Text] [Related]
18. 4-aryl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thione derivatives: synthesis, enantiomeric separation and in vitro screening as calcium antagonists.
Saraç S; Yarim M; Ertan M; Erol K; Aktan Y
Boll Chim Farm; 1997 Dec; 136(11):657-64. PubMed ID: 9534262
[TBL] [Abstract][Full Text] [Related]
19. Thiazolo[3,2-a]pyrimidine derivatives as calcium antagonists.
Balkan A; Uma S; Ertan M; Wiegrebe W
Pharmazie; 1992 Sep; 47(9):687-8. PubMed ID: 1475316
[TBL] [Abstract][Full Text] [Related]
20. New thiazolo[3,2-a] pyrimidine derivatives, synthesis and calcium antagonistic activities.
Balkan A; Tozkoparan B; Ertan M; Sara Y; Ertekin N
Boll Chim Farm; 1996 Dec; 135(11):648-52. PubMed ID: 9138461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
